NewAmsterdam is an innovative biotech company with experience and expertise to deliver across its ambitious clinical, regulatory, and commercial goals. Our robust scientific approach focuses on advancing a new era of life-saving treatments for lipid-related disorders. Over the last decade it has become apparent that one of the major risk factors for Alzheimer’s disease, Apolipoprotein E4, is closely associated with lipid dysregulation in the brain. Based on published data from a pre-specified analysis in our phase III BROADWAY trial evaluating Alzheimer’s disease biomarkers in patients with ASCVD, including patients with at lese one ApoE4 allele, we are excited to initiate a Alzheimer’s Disease clinical program. We are looking to recruit an Executive Medical Director, Alzheimer’s Disease to strengthen our team, which is led by a world-class team of industry veterans and key opinion leaders, including some of the world’s preeminent cardiometabolic experts. The Executive Medical Director, Alzheimer’s Disease will lead the design, monitoring, data analysis, and interpretation of the Company’s clinical trials in Alzheimer’s Disease. As such, the Executive Medical Director, Alzheimer’s Disease is a critically important and visible member of the clinical development team. The Executive Medical Director, Alzheimer’s Disease position is a remote position based in either the United States or the Netherlands and will report to the Chief Development Officer.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Education Level
Ph.D. or professional degree
Number of Employees
11-50 employees